ASCO 2023: Cell Therapy Post-Conference Report

Beacon Adoptive Cell experts have screened each abstract from the 2023 ASCO Annual Meeting, held on 2nd to 6th June. This year, 100 adoptive cell-relevant abstracts (84 clinical and 16 preclinical) were identified and have been listed in order of presentation in our Post-Conference Report.

ASCO 2023: Cell Therapy Abstract Highlights

This post-conference report offers a complete guide to all the adoptive cell topics and provides analysis and a summary of abstracts. MostĀ of the presented data at the ASCO Annual Meeting showcased preclinical data. Find all about them by downloading the report.

You May Also Be Interested In…

Learn More About Cell Therapy

What is Beacon Cell Therapy?
  • The Most Comprehensive Way to Search the Cell Therapy Development Landscape: Unique search ontologies based on Cell Therapy drug and trial characteristics
  • Market Leading Approach to Cell Therapy Preclinical & Clinical Data Curation: Manual curation of key Cell Therapy research and development data points by Cell Therapy research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cell Therapy company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Cell Therapy

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search